Despite continuing efforts during the last decades, there is no 'ideal prosthetic valve
substitute'. Every valve prosthesis invokes new pathophysiological processes, including the …

Background Recent recommendations suggest that in patients with severe aortic stenosis
undergoing transcatheter aortic valve implantation and coexistent significant coronary artery …

Objectives To examine the relationship between periprocedural bleeding complications and
major adverse cardiovascular events (MACEs) and mortality outcomes following …

Aims Patient access to reperfusion therapy and the use of primary percutaneous coronary
intervention (p-PCI) or thrombolysis (TL) varies considerably between European countries …

Objectives: The objective was to define the characteristics of a real-world patient population
treated with transcatheter aortic valve implantation (TAVI), regardless of technology or …

Aims Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion
therapy in ST-elevation myocardial infarction (STEMI). We conducted this study to evaluate …

Background: Percutaneous coronary intervention (PCI) of coronary bifurcation lesions
remains a subject of debate. Many studies have been published in this setting. They are …

Background—We assessed trends in the performance of transcatheter aortic valve
implantation in the United Kingdom from the first case in 2007 to the end of 2012. We …

Background The fear of contagion during the coronavirus disease-2019 (COVID-19)
pandemic may have potentially refrained patients with ST-segment elevation myocardial …

Background: Very little is known about long-term valve durability after transcatheter aortic
valve replacement (TAVR). Objectives: This study sought to evaluate the incidence of …